| Cat.No. | Name | Information |
|---|---|---|
| M8538 | ML354 | ML354 is a potent and selective PAR4 (protease activated receptor-4) antagonist. |
| M54388 | FSLLRY-NH2 | FSLLRY-NH2 is a protease-activated receptor 2 (PAR2) inhibitor. |
| M54138 | PAR-2 (1-6) (human) | PAR-2 (1-6) (human) (SLIGKV), a peptide ligand, is a PAR-2 agonist. |
| M49480 | NRD-21 | NRD-21 is an allosteric inhibitor of PAR1 Gq signaling, with IC50 of 0.38 uM in intracellular calcium mobilization assay. NRD-21 has improved anti-Inflammatory activity and is much more plasma stable than ML161, it is a promising lead compound for the parmodulin class for anti-thrombotic and anti-inflammatory indications research. |
| M31169 | Parstatin (mouse) TFA | Parstatin (mouse) TFA is a peptide formed by protein hydrolysis upon PAR1 receptor activation and is also a PAR-1 agonist with cellular permeability. In addition, Parstatin (mouse) TFA is also a potent inhibitor of angiogenesis. It can be used in studies related to ischemia-reperfusion injury. |
| M31168 | TFLLR-NH2 (TFA) | TFLLR-NH2 (TFA) is a selective protease-activated receptor 1 (PAR1) agonist with an EC50 value of 1.9 μM. |
| M21516 | PZ-128 | PZ-128 (P1pal-7), a cell-penetrating peptide, is a first-in-class, specific and reversible protease activating receptor 1 (PAR1) antagonist. It has anti-platelet, anti-metastasis, anti-angiogenesis and anticancer effects. |
| M14047 | FSLLRY-NH2 TFA | FSLLRY-NH2 TFA is a protease-activated receptor 2 (PAR2) inhibitor. |
| M10238 | PAR-2 (6-1) amide (human) | VKGILS-NH2 is a reversed amino acid sequence control peptide for SLIGKV-NH2. |
| M10237 | Protease-Activated Receptor-2, amide | Protease-Activated Receptor-2, amide (SLIGKV-NH2) is a highly potent agonist of PAR2 with IC50 of 10.4 uM. |
| M10236 | PAR-2 (1-6) (mouse, rat) | PAR-2 (1-6) (mouse, rat) is a PAR2 activator, it can be used to explore signaling through PAR2 in cells. |
| M10235 | SLIGRL-NH2 | SLIGRL-NH2 (Protease-Activated Receptor-2 Activating Peptide) is an agonist of Protease-Activated Receptor-2 (PAR-2). |
| M10143 | AZ3451 | AZ3451 is a potent PAR2 (protease-activated receptor-2) antagonist with IC50 of 23 nM, which plays a part in inflammation response, apoptosis, autophagy and cellular senescence during Osteoarthritis (OA). |
| M9814 | (Ala1)-PAR-4 (1-6) (mouse) | (Ala1)-PAR-4 (1-6) (mouse) |
| M9813 | PAR-4 (1-6) (mouse) | PAR-4 (1-6) (mouse) |
| M9812 | PAR-4 (1-6) (human) | PAR-4 (1-6) (human) is an N-terminal fragment of protease-activated receptor 4 (PAR4) that acts as a PAR4 agonist. |
| M6243 | Vorapaxar Sulfate | Vorapaxar is a first-in-class, potent and orally-active protease-activated receptor 1 (PAR-1) antagonist that blocks thrombin-mediated platelet activation without interfering with thrombin-mediated fibrin deposition. |
| M3123 | Vorapaxar | Vorapaxar (SCH 530348) is a potent and orally active thrombin receptor (PAR-1) antagonist with Ki of 8.1 nM. |
| M2574 | ML161 | Parmodulin 2 (ML161) is an allosteric inhibitor of PAR1 with IC50 of 0.26 μM. |
| M56318 | SCH79797 dihydrochloride | SCH79797 dihydrochloride is a highly potent, selective nonpeptide protease activated receptor 1 (PAR1) antagonist. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
